Geneos Wealth Management’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Geneos Wealth Management’s Portfolio MSTZ Stock Details MSTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.1K	Buy	+5,028	New	+$42.4K	﹤0.01%	1313
2025 Q4	–	Sell	-7,407	Closed	-$39K	–	2577
2025 Q3	$39K	Sell	7,407 -10,399	-58%	-$46.6K	﹤0.01%	1472
2025 Q2	$74.4K	Buy	+17,806	New	+$112K	﹤0.01%	1381

Other funds holding MSTZ

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Geneos Wealth Management's MSTZ Position: Q2 2026 in Review

Geneos Wealth Management opened a new position in T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q2 2026: 5,028 shares worth $78.1K. The stake represents ﹤0.01% of the portfolio and ranks #1313 among its holdings. This is a return to the name: Geneos Wealth Management previously reported a position in MSTZ as recently as Q3 2025.

Geneos Wealth Management first reported a position in MSTZ in Q2 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold MSTZ as of Q2 2026.

Geneos Wealth Management held 5,028 shares of T-Rex 2X Inverse MSTR Daily Target ETF worth $78.1K as of Q2 2026.
T-Rex 2X Inverse MSTR Daily Target ETF was a new Geneos Wealth Management position in Q2 2026.
T-Rex 2X Inverse MSTR Daily Target ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1313 holding.
Geneos Wealth Management first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q2 2025 and has held it in 3 quarters since.
4 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.